Ruth Nash
St George's Hospital
9 Papers
50 Citations
Ruth Nash is an academic researcher from St George's Hospital. The author has contributed to research in topics: Osteopathia striata & Molecular pathology. The author has an hindex of 5, co-authored 9 publications.
Chat about Author
Papers
Does transitional zone pull-through in Hirschsprung's disease imply a poor prognosis?
Marie-Klaire Farrugia,Nicholas Alexander,Simon A. Clarke,Ruth Nash,Eric A. Nicholls,Keith Holmes +5 more
TL;DR: Up to one third of patients with TZPT will require revisional surgery for intractable symptoms and Vigilance is warranted in view of the greater risk of enterocolitis and Continence is not significantly affected.
44
The Male Phenotype in Osteopathia Striata Congenita With Cranial Sclerosis
Sarah K. Holman,Phil Daniel,Zandra A. Jenkins,Rachel L. Herron,Timothy R. Morgan,Ravi Savarirayan,Chung Wo Chow,Axel Bohring,Annette Mosel,Didier Lacombe,Bernhard Steiner,Thomas Schmitt-Mechelke,Barbara Schroter,Annick Raas-Rothschild,Sixto Garcia Minaur,Mary Porteous,Michael W. Parker,Oliver Quarrell,Dagmar Tapon,Valérie Cormier-Daire,Sahar Mansour,Ruth Nash,Laurence A. Bindoff,Torunn Fiskerstrand,Stephen P. Robertson +24 more
TL;DR: The observation of striations in males may be indicative of a WTX mutation in a mosaic state supporting the contention that this sign in females is indicative of the differential lyonization of cells in the osteoblastic lineage.
35
Germline CBL mutation associated with a noonan-like syndrome with primary lymphedema and teratoma associated with acquired uniparental isodisomy of chromosome 11q23.
Helen L. Hanson,Meredith Wilson,John P. Short,Barry A. Chioza,Andrew H. Crosby,Ruth Nash,Karen Marks,Sahar Mansour +7 more
TL;DR: A girl with a Noonan‐like phenotype of bilateral ptosis, lymphedema of the lower limbs and moderate intellectual disability, due to a de novo heterozygous mutation in CBL is described, suggesting a specific association of CBL mutations in germ cell tumor predisposition.
25
Clinical features of molecular pathology of solid tumours in childhood.
TL;DR: Tumour biology now plays an important part in identifying appropriate treatment through more accurate diagnoses and new risk stratifications based on molecular markers.
15
Treatment of High Risk Sertoli–Leydig Cell Tumors of the Ovary Using a Gonadotropin Releasing Hormone (GnRH) Analog
Harsha Prasada Lashkari,Ruth Nash,Assunta Albanese,Bruce Okoye,Robert P. Millar,Robert P. Millar,Robert P. Millar,Kathy Pritchard-Jones,Kathy Pritchard-Jones +8 more
TL;DR: The use of GnRH analog to lower gondadotropin and potentially directly inhibit the tumors through expressed GnRH receptors was exploited to reduce the risk of recurrence and to use it as maintenance antitumor therapy for 2 years after completion of chemotherapy.